Gsa Capital Partners LLP Procept Bio Robotics Corp Call Options Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRCT
# of Institutions
290Shares Held
43.9MCall Options Held
266KPut Options Held
78.8K-
Vanguard Group Inc Valley Forge, PA5.25MShares$203 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$135 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.16MShares$83.3 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.53MShares$59 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.32MShares$51 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $1.72B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...